

Talaris Therapeutics Inc, a biotechnology company, has raised $115 million in Series B funding. Surveyor Capital and Viking Global Investors led the round.
Source: Press Release
Talaris Therapeutics Inc, a biotechnology company, has raised $115 million in Series B funding.
Talaris Therapeutics Inc, a biotechnology company, has raised $115 million in Series B funding. Surveyor Capital and Viking Global Investors led the round.
Source: Press Release
Copyright PEI Media
Not for publication, email or dissemination